Insider Buying: Transcat (NASDAQ:TRNS) CEO Buys 2,275 Shares of Company Stock

Key Points

• CEO Jaime Irick bought 2,275 Transcat shares at an average price of $101.26, investing about $230,367; the purchase was disclosed in an SEC filing.
• Transcat beat quarterly expectations, reporting EPS of $0.64 versus the $0.45 consensus and revenue of $97.09 million versus forecasts of $92.46 million.
• Analyst views were mixed but included several upgrades to Outperform; the consensus rating remained Hold, with an average price target of $108.33.

Transcat, Inc. (NASDAQ:TRNS - Get Free Report) CEO Jaime Irick bought 2,275 shares of the firm's stock in a transaction dated Thursday, November 5th. The shares were acquired at an average price of $101.26 per share, with a total value of $230,366.50. Following the completion of the transaction, the chief executive officer owned 2,275 shares of the company's stock, valued at approximately $230,366.50. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Transcat Stock Up 1.1%

TRNS stock traded up $1.13 during trading on Friday, hitting $101.51. 169,038 shares of the company's stock traded hands, compared to its average volume of 148,901. The firm has a market capitalization of $954.19 million, a P/E ratio of 211.48 and a beta of 0.61. The company has a quick ratio of 2.11, a current ratio of 2.57 and a debt-to-equity ratio of 0.38. The business has a fifty day simple moving average of $86.71 and a two-hundred day simple moving average of $82.24. Transcat, Inc. has a 1 year low of $50.23 and a 1 year high of $110.47.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.19. The company had revenue of $97.09 million during the quarter, compared to analysts' expectations of $92.46 million. Transcat had a return on equity of 6.14% and a net margin of 1.26%. Sell-side analysts anticipate that Transcat, Inc. will post 1.84 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. CJS Securities began coverage on shares of Transcat in a research note on Tuesday, October 27th. They set an "outperform" rating and a $115.00 target price for the company. Oppenheimer raised Transcat from a "market perform" rating to an "outperform" rating and set a $115.00 price target for the company in a research note on Wednesday. Northland Securities upgraded Transcat from a "market perform" rating to an "outperform" rating and set a $95.00 price objective on the stock in a report on Wednesday, October 21st. Finally, Weiss Ratings reiterated a "sell (d+)" rating on shares of Transcat in a research note on Tuesday, August 25th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Transcat presently has a consensus rating of "Hold" and a consensus price target of $108.33.

Transcat News Roundup

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Zacks upgraded Transcat to Rank #1 (Strong Buy), citing improving earnings prospects, and included TRNS on its Strong Buy momentum-stock list. Zacks Strong Buy upgrade
• Positive Sentiment: Northland Securities raised its EPS forecasts across 2027–2031, including lifting its FY2027 estimate to $2.00 from $1.71 and its FY2031 estimate to $3.69 from $3.53. The revisions suggest stronger expected earnings growth. Northland estimate revisions
• Positive Sentiment: Oppenheimer raised its rating on Transcat to Outperform, adding to the favorable analyst sentiment. Oppenheimer rating upgrade
• Positive Sentiment: Recent coverage linked TRNS reaching a 52-week high to an earnings beat and improved outlook. The supplied background also reports quarterly EPS of $0.64 versus a $0.45 consensus estimate, with revenue above forecasts. Transcat 52-week high following earnings beat
• Neutral Sentiment: Northland maintained an Outperform rating but set a $95 price target, below the $101.32 share price cited in the background; this may temper the impact of its higher earnings forecasts. Northland rating and target

Institutional Investors Weigh In On Transcat

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Integrated Wealth Concepts LLC bought a new stake in shares of Transcat during the second quarter worth $32,000. Persistent Asset Partners Ltd acquired a new stake in Transcat during the second quarter worth approximately $52,000. GAMMA Investing LLC boosted its position in shares of Transcat by 133.6% in the third quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company's stock valued at $91,000 after acquiring an additional 589 shares during the period. Canada Pension Plan Investment Board acquired a new position in Transcat in the 2nd quarter valued at $204,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of Transcat during the 2nd quarter worth approximately $226,000. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Company Profile

Transcat, Inc NASDAQ: TRNS provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.